Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selenium deficiency-induced cardiomyopathy: a case report.

European heart journal. Case reports·2026
Same author

Response by Yamada et al to Letter Regarding Article, "Cardiac Reprogramming and Gata4 Overexpression Reduce Fibrosis and Improve Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction".

Circulation·2025
Same author

Characteristics of Sudden Cardiac Arrest in Young Athletes: A Web-Based Survey of Athletes in Japanese College Sports.

Cardiology research and practice·2025
Same author

Association between the baseline health status and long-term outcomes after catheter ablation for atrial fibrillation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025
Same author

Age and Health Status Benefits Following Initiation of Atrial Fibrillation-Specific Treatments.

Journal of the American Heart Association·2025
Same author

Impact of Peridevice Leak on Clinical Outcomes After Left Atrial Appendage Closure: The OCEAN-LAAC Registry.

Journal of the American Heart Association·2025

Related Experiment Video

Updated: Mar 7, 2026

Assessing Cardiac Reprogramming using High Content Imaging Analysis
06:02

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Published on: October 26, 2020

1.5K

Discovery and progress of direct cardiac reprogramming.

Hidenori Kojima1, Masaki Ieda2,3

  • 1Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Cellular and Molecular Life Sciences : CMLS
|February 16, 2017
PubMed
Summary

Direct cardiac reprogramming converts fibroblasts into cardiomyocyte-like cells using specific factors. While promising for heart regeneration, human cell reprogramming efficiency needs improvement for clinical use.

Keywords:
CardiomyocyteDirect cardiac reprogrammingFibroblastRegenerationTranscription factor

More Related Videos

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

7.9K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.8K

Related Experiment Videos

Last Updated: Mar 7, 2026

Assessing Cardiac Reprogramming using High Content Imaging Analysis
06:02

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Published on: October 26, 2020

1.5K
Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

7.9K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.8K

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Molecular Biology

Background:

  • Cardiac disease is a leading global cause of mortality.
  • Direct cardiac reprogramming offers a novel strategy for cardiac regenerative therapy.
  • Transcription factors are key regulators in cell fate determination.

Purpose of the Study:

  • To explore the potential of direct cardiac reprogramming for generating cardiomyocyte-like cells.
  • To investigate the efficiency of cardiac reprogramming in different cell types and species.
  • To identify barriers and mechanisms for improving cardiac reprogramming for clinical applications.

Main Methods:

  • Utilized a combination of cardiac-specific transcription factors (Gata4, Mef2c, Tbx5 - GMT) to reprogram fibroblasts.
  • Generated induced cardiomyocyte-like cells (iCMs) from mouse fibroblasts.
  • Evaluated improvements in reprogramming efficiency and in vivo applications.

Main Results:

  • Successfully demonstrated direct reprogramming of mouse fibroblasts into iCMs using the GMT factors.
  • Showcased advancements in reprogramming efficiency, in vivo direct cardiac reprogramming for heart regeneration, and human cell reprogramming.
  • Identified that reprogramming in human cells and adult fibroblasts remains inefficient.

Conclusions:

  • Direct cardiac reprogramming is a viable approach for generating cardiomyocyte-like cells.
  • Further research into epigenetic barriers and molecular mechanisms is crucial for enhancing reprogramming efficiency.
  • This technology holds significant potential for future clinical applications in treating heart disease.